Skip to main content
SpringerLink
Log in

Seizures in Cancer Patients

  • Chapter
Seizures

Part of the book series: Current Clinical Neurology ((CCP))

  • 328 Accesses

Abstract

It is estimated that at least 15% of all cancer patients will have a symptomatic neurologic complication during the course of their disease (1). With 1 million new cases of cancer diagnosed in the United States each year, neurologic complications of cancer are therefore a relatively common medical problem (2).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Posner JB. Neurologic Complication of Cancer. Philadelphia, PA: FA Davis, 1995.

    Google Scholar 

  2. Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics. CA Cancer J Clin 1994; 44: 7–26.

    Article  PubMed  CAS  Google Scholar 

  3. Gilbert MR, Grossman SA. Incidence and nature of neurologic problems in patients with solid tumors. Am J Med 1986; 81: 951–954.

    Article  PubMed  CAS  Google Scholar 

  4. Boggs JG. Seizures in medically complex patients. Epilepsia 1997; 38 (Suppl 4): S55 - S59.

    Article  PubMed  Google Scholar 

  5. Miller RB. Central nervous system manifestations of fluid and electrolyte disturbances. Surg Clin North Am 1968; 48: 381–393.

    PubMed  CAS  Google Scholar 

  6. Ettinger AB. Structural causes of epilepsy. Tumors, cysts, stroke, and vascular malformations. Neurol Clin 1994; 12: 41–56.

    PubMed  CAS  Google Scholar 

  7. LeBlanc FE. Cerebral seizures and brain tumors. In: Vinken PJ, Bruyn GW (eds.), Handbook of Clinical Neurology. Amsterdam: North Holland, 1974, pp 295–301.

    Google Scholar 

  8. Cascino GD. Epilepsy and brain tumors: implications for treatment. Epilepsia 1990; 31 (Suppl 3): 537 — S44.

    Article  Google Scholar 

  9. Bartolomei JC, Christopher S, Vives K, Spencer DD, Piepmeier JM. Low-grade gliomas of chronic epilepsy: a distinct clinical and pathological entity. J Neurooncol 1997; 34: 79–84.

    Article  PubMed  CAS  Google Scholar 

  10. Ketz E. Brain Tumors and Epilepsy. In: Vinken PJ, Bruyn GW, editors: Handbook of Clinical Neurology. Amsterdam: North Holland, 1974: 254–269.

    Google Scholar 

  11. Moots PL, Maciunas RJ, Eisert DR, Parker RA, Laporte K, Abou-Khalil B. The course of seizure disorders in patients with malignant gliomas. Arch Neurol 1995; 52: 717–724.

    Article  PubMed  CAS  Google Scholar 

  12. Berger MS, Ghatan S, Geyer JR, Keles GE, Ojemann GA. Seizure outcome in children with hemispheric tumors and associated intractable epilepsy: the role of tumor removal combined with seizure foci resection. Pediatr Neurosurg 1991; 17: 185–191.

    Article  PubMed  Google Scholar 

  13. Morris HH, Estes ML. In: Wyllie E (ed.), The Treatment of Epilepsy: Principles and Practice. Philadelphia, PA: Leas and Febiger, 1993, pp 659–666.

    Google Scholar 

  14. Spencer DD, Spencer SS, Mattson RH, Williamson PD. Intracerebral masses in patients with intractable partial epilepsy. Neurology 1984; 34: 432–436.

    Article  PubMed  CAS  Google Scholar 

  15. Vertosick FT, Jr., Selker RG, Arena VC. Survival of patients with well-differentiated astrocytomas diagnosed in the era of computed tomography. Neurosurgery 1991; 28: 496–501.

    Article  PubMed  Google Scholar 

  16. Piepmeier JM. Observations on the current treatment of low-grade astrocytic tumors of the cerebral hemispheres. J Neurosurg 1987; 67: 177–181.

    Article  PubMed  CAS  Google Scholar 

  17. Adams RD, Victor M. Principles of Neurology, 3rd ed. New York: McGraw-Hill, 1985.

    Google Scholar 

  18. Fried I, Kim JH, Spencer DD. Limbic and neocortical gliomas associated with intractable seizures: a distinct clinicopathological group. Neurosurgery 1994; 34: 815–823.

    Article  PubMed  CAS  Google Scholar 

  19. Berger MS, Ojemann GA, Lettich E. Neurophysiological monitoring during astrocytoma surgery. Neurosurg Clin N Am 1990; 1: 65–80.

    PubMed  CAS  Google Scholar 

  20. Grisar TM. Neuron-glia relationships in human and experimental epilepsy: a biochemical point of view. Adv Neurol 1986; 44: 1045–1073.

    PubMed  CAS  Google Scholar 

  21. Strowbridge BW, Masukawa LM, Spencer DD, Shepherd GM. Hyperexcitability associated with localizable lesions in epileptic patients. Brain Res 1992; 587: 158–163.

    Article  PubMed  CAS  Google Scholar 

  22. Haglund MM, Berger MS, Kunkel DD, Franck JE, Ghatan S, Ojemann GA. Changes in gamma-aminobutyric acid and somatostatin in epileptic cortex associated with low-grade gliomas. J Neurosurg 1992; 77: 209–216.

    Article  PubMed  CAS  Google Scholar 

  23. Bateman DE, Hardy JA, McDermott JR, Parker DS, Edwardson JA Amino acid neurotransmitter levels in gliomas and their relationship to the incidence of epilepsy. Neurol Res 1988; 10: 112–114.

    PubMed  CAS  Google Scholar 

  24. Eliashiv SD, Dewar S, Wainwright I, Engel J Jr., Fried I. Long-term follow-up after temporal lobe resection for lesions associated with chronic seizures. Neurology 1997; 48: 621–626.

    Article  PubMed  CAS  Google Scholar 

  25. Kirkpatrick PJ, Honavar M, Janota I, Polkey CE. Control of temporal lobe epilepsy following en bloc resection of low-grade tumors. J Neurosurg 1993; 78: 19–25.

    Article  PubMed  CAS  Google Scholar 

  26. Berger MS, Ghatan S, Haglund MM, Dobbins J, Ojemann GA. Low-grade gliomas associated with intractable epilepsy: seizure outcome utilizing electrocorticography during tumor resection. J Neurosurg 1993; 79: 62–69.

    Article  PubMed  CAS  Google Scholar 

  27. Whittle IR, Beaumont A. Seizures in patients with supratentorial oligodendroglial tumours. Clinicopathological features and management considerations. Acta Neu-rochir (Wien) 1995; 135: 19–24.

    Article  CAS  Google Scholar 

  28. Rogers LR, Morris HH, Lupica K. Effect of cranial irradiation on seizure frequency in adults with low-grade astrocytoma and medically intractable epilepsy. Neurology 1993; 43: 1599–1601.

    Article  PubMed  CAS  Google Scholar 

  29. Morrell F. Secondary epileptogenesis in man. Arch Neurol 1985; 42: 318–335.

    Article  PubMed  CAS  Google Scholar 

  30. Boarini DJ, Beck DW, VanGilder JC. Postoperative prophylactic anticonvulsant therapy in cerebral gliomas. Neurosurgery 1985; 16: 290–292.

    Article  PubMed  CAS  Google Scholar 

  31. Glantz MJ, Cole BF, Friedberg MH, et al. A randomized, blinded, placebocontrolled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors. Neurology 1996; 46: 985–991.

    Article  PubMed  CAS  Google Scholar 

  32. Chalk JB, Ridgeway K, Brophy T, Yelland JD, Eadie MJ. Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients. J Neurol Neurosurg Psychiatry 1984; 47: 1087–1090.

    Article  PubMed  CAS  Google Scholar 

  33. Hague N, Thrasher K, Werk EE Jr., Knowles HC Jr., Sholiton LJ. Studies on dexamethasone metabolism in man: effect of diphenylhydantoin. J Clin Endocrinol Metab 1972; 34: 44–50.

    Article  Google Scholar 

  34. Delattre JY, Safai B, Posner JB. Erythema multiforme and Stevens-Johnson syndrome in patients receiving cranial irradiation and phenytoin. Neurology 1988; 38: 194–198.

    Article  PubMed  CAS  Google Scholar 

  35. Khe HX, Delattre JY, Poisson M. Stevens-Johnson syndrome in a patient receiving cranial irradiation and carbamazepine. Neurology 1990; 40: 1144–1145.

    Article  Google Scholar 

  36. Kikuchi K, McCormick CI, Neuwelt EA. Immunosuppression by phenytoin: implication for altered immune competence in brain-tumor patients. J Neurosurg 1984; 61: 1085–1090.

    Article  PubMed  CAS  Google Scholar 

  37. Byrne TN, Cascino TL, Posner JB. Brain metastasis from melanoma. J Neurooncol 1983; 1: 313–317.

    Article  PubMed  CAS  Google Scholar 

  38. Kobayashi T, Kida Y, Yoshida J, Shibuya N, Kageyama N. Brain metastasis of choriocarcinoma. Surg Neurol 1982; 17: 395–403.

    Article  PubMed  CAS  Google Scholar 

  39. Sorensen JB, Hansen HH, Hansen M, Dombernowsky P. Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis. J Clin Oncol 1988; 6: 1474–1480.

    PubMed  CAS  Google Scholar 

  40. Sarma DP, Godeau L. Brain metastasis from prostatic cancer. J Surg Oncol 1983; 23: 173–174.

    Article  PubMed  CAS  Google Scholar 

  41. Abrey LE, Dalmau JO. Neurologic complications of ovarian carcinoma. Cancer 1999; 85: 127–133.

    Article  PubMed  CAS  Google Scholar 

  42. Sapozink MD, Kaplan HS. Intracranial Hodgkin’s disease. A report of 12 cases and review of the literature. Cancer 1983; 52: 1301–1307.

    Article  PubMed  CAS  Google Scholar 

  43. Gerl A, Clemm C, Kohl P, Schalhorn A, Wilmanns W. Central nervous system as sanctuary site of relapse in patients treated with chemotherapy for metastatic testicular cancer. Clin Exp Metastasis 1994; 12: 226–230.

    Article  PubMed  CAS  Google Scholar 

  44. Boogerd W. Central nervous system metastasis in breast cancer. Radiother Oncol 1996; 40: 5–22.

    Article  PubMed  CAS  Google Scholar 

  45. Baethmann A, Maier-Hauff K, Kempski O, Unterberg A, Wahl M. Therapeutic considerations in blood-brain barrier disturbances. Acta Neuropathol Suppl (Berlin) 1983; 8: 119–128.

    Article  CAS  Google Scholar 

  46. Delattre J-Y, Posner JB. The blood-brain barrier: Morphology, physiology and its change in cancer patients. In: Hildebrand J (ed.), Neurological Adverse Reactions to Anticancer Drugs. Berlin: Springer-Verlag, 1990, pp 3–24.

    Chapter  Google Scholar 

  47. Delattre JY, Krol G, Thaler HT, Posner JB. Distribution of brain metastases. Arch Neurol 1988; 45: 741–744.

    Article  PubMed  CAS  Google Scholar 

  48. Cohen N, Strauss G, Lew R, Silver D, Recht L. Should prophylactic anticonvulsants be administered to patients with newly-diagnosed cerebral metastases? A retrospective analysis. J Clin Oncol 1988; 6: 1621–1624.

    PubMed  CAS  Google Scholar 

  49. Simonescu ME. Metastatic tumors of the brain. A follow-up study of 195 patients with neurosurgical considerations. J Neurosurg 1960; 17: 361–373.

    Article  Google Scholar 

  50. Sammaritano M, de Lotbiniere A, Andermann F, Olivier A, Gloor P, Quesney LF. False lateralization by surface EEG of seizure onset in patients with temporal lobe epilepsy and gross focal cerebral lesions. Ann Neurol 1987; 21: 361–369.

    Article  PubMed  CAS  Google Scholar 

  51. Mathern GW, Babb TL, Vickrey BG, Melendez M, Pretorius JK. The clinical-pathogenic mechanisms of hippocampal neuron loss and surgical outcomes in temporal lobe epilepsy. Brain 1995; 118: 105–118.

    Article  PubMed  Google Scholar 

  52. Mones RJ. Increased intracranial pressure due to metastatic disease of venous sinuses. A report of six cases. Neurology 1965; 15: 1000–1007.

    Article  PubMed  CAS  Google Scholar 

  53. Stark RJ, Henson RA. Cerebral compression by myeloma. J Neurol Neurosurg Psychiatry 1981; 44: 833–836.

    Article  PubMed  CAS  Google Scholar 

  54. Perry JR, Bilbao JM. Metastatic alveolar soft part sarcoma presenting as a duralbased cerebral mass Neurosurgery 1994; 34: 168–170.

    Article  PubMed  CAS  Google Scholar 

  55. Hiraki A, Tabata M, Ueoka H, et al. Direct intracerebral invasion from skull metastasis of large cell lung cancer. Intern Med 1997; 36: 720–723.

    Article  PubMed  CAS  Google Scholar 

  56. Nagayama I, Katoh H, Sakumoto M, Itoh M, Yoshida K. Subdural hematoma associated with dural metastasis from paranasal sinus cancer: a case report and review of the literature. ORL J Otorhinolaryngol Relat Spec 1993; 55: 240–243.

    Article  CAS  Google Scholar 

  57. Hayashi M, Handa Y, Kobayashi H, Kawano H, Ishii H, Hirose S. Plateau-wave phenomenon (I). Correlation between the appearance of plateau waves and CSF circulation in patients with intracranial hypertension. Brain 1991; 114: 2681–2691.

    Article  PubMed  Google Scholar 

  58. Boogerd W, Vos VW, Hart AAM, et al. Brain metastases in breast cancer; natural history, prognostic factors and outcome. J Neurooncol 1993; 15: 165–174.

    Article  PubMed  CAS  Google Scholar 

  59. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998; 280: 1485–1489.

    Article  PubMed  CAS  Google Scholar 

  60. Breneman JC, Warnick RE, Albright REJ, Kukiatinant N, Shaw J, Armin D, et al. Stereotactic radiosurgery for the treatment of brain metastases. Results of a single institution series. Cancer 1997; 79: 551–557.

    Article  PubMed  CAS  Google Scholar 

  61. Sampson JH, Carter JHJ, Friedman AH, Seigler HF. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 1998; 88: 11–20.

    Article  PubMed  CAS  Google Scholar 

  62. Hung S, Hilsenbeck S, Feun L. Seizure prophylaxis with phenytoin in patients with brain metastasis. Proc Am Soc Clin Oncol 1991; 10: 327.

    Google Scholar 

  63. Weaver S, Forsyth P, Fulton D. A prospective randomized study of prophylactic anticonvulsants in patients with primary brain tumors or metastatic brain tumors and without prior seizures. Neurology 1995; 45: A263.

    Google Scholar 

  64. Avrahami E, Weiss-Peretz J, Cohn DF. Epilepsy in patients with brain metastases triggered by intravenous contrast medium. Clin Radiol 1989; 40: 422–423.

    Article  PubMed  CAS  Google Scholar 

  65. Scott WR. Seizures: a reaction to contrast media for computed tomography of the brain. Radiology 1980; 137: 359–361.

    PubMed  CAS  Google Scholar 

  66. Pagani JJ, Hayman LA, Bigelow RH, Libshitz HI, Lepke RA, Wallace S. Diazepam prophylaxis of contrast media-induced seizures during computed tomography of patients with brain metastases. Am J Roentgenol 1983; 140: 787–792.

    CAS  Google Scholar 

  67. Gasecki AP, Bashir RM, Foley J. Leptomeningeal carcinomatosis: A report of 3 cases and review of the literature. Eur Neurol 1992; 32: 74–78.

    Article  PubMed  CAS  Google Scholar 

  68. Balm M, Hammack J. Leptomeningeal carcinomatosis. Presenting features and prognostic factors. Arch Neurol 1996; 53: 626–632.

    Article  PubMed  CAS  Google Scholar 

  69. Kaplan JG, DeSouza TG, et al. Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neurooncol 1990; 9: 225–229.

    Article  PubMed  CAS  Google Scholar 

  70. Posner JB, Chernik NL. Intracranial metastases from systemic cancer. Adv Neurol 1978; 19: 575–587.

    Google Scholar 

  71. Ersboll J, Schultz HB, Thomsen BL, Keiding N, Nissen NI. Meningeal involvement in non-Hodgkin’s lymphoma: symptoms, incidence, risk factors and treatment. Scand J Haematol 1985; 35: 487–496.

    Article  PubMed  CAS  Google Scholar 

  72. Dekker AW, Elderson A, Punt K, Sixma JJ. Meningeal involvement in patients with acute nonlymphocytic leukemia. Incidence, management, and predictive factors. Cancer 1985; 56: 2078–2082.

    Article  PubMed  CAS  Google Scholar 

  73. Hoerni-Simon G, Suchaud JP, Eghbali H, Coindre JM, Hoerni B. Secondary involvement of the central nervous system in malignant non-Hodgkin’s lymphoma. A study of 30 cases in a series of 498 patients. Oncology 1987; 44: 98–101.

    Article  PubMed  CAS  Google Scholar 

  74. Little JR, Dale AJ, Okazaki H. Meningeal carcinomatosis. Clinical manifestations. Arch Neurol 1974; 30: 138–143.

    Article  PubMed  CAS  Google Scholar 

  75. Olson ME, Chernik NL, Posner JB. Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study. Arch Neurol 1974; 30: 122–137.

    Article  PubMed  CAS  Google Scholar 

  76. Broderick JP, Cascino TL. Nonconvulsive status epilepticus in a patient with leptomeningeal cancer. Mayo Clin Proc 1987; 62: 835–837.

    PubMed  CAS  Google Scholar 

  77. Graus F, Rogers LR, Posner JB. Cerebrovascular complications in patients with cancer. Medicine 1985; 64: 16–35.

    Article  PubMed  CAS  Google Scholar 

  78. Rogers LR. Cerebrovascular complications in cancer patients. Oncology 1994; 8: 23–30.

    PubMed  CAS  Google Scholar 

  79. Rogers LR, Cho ES, Kempin S, Posner JB. Cerebral infarction from non-bacterial thrombotic endocarditis. Clinical and pathological study including the effects of anticoagulation. Am J Med 1987; 83: 746–756.

    Article  PubMed  CAS  Google Scholar 

  80. Mandybur TI. Intracranial hemorrhage caused by metastatic tumors. Neurology 1977; 27: 650–655.

    Article  PubMed  CAS  Google Scholar 

  81. Wakai S, Yamakawa K, Manaka S, Takakura K. Spontaneous intracranial hemorrhage caused by brain tumor: its incidence and clinical significance. Neurosurgery 1982; 10: 437–444.

    Article  PubMed  CAS  Google Scholar 

  82. Paillas JE, Pellet W. Brain Metastasis. In: Vinken PJ, Bruyn GW (eds.), Handbook of Clinical Neurology. New York: Elsevier, 1975, pp 201–232.

    Google Scholar 

  83. Bick RL. Coagulation abnormalities in malignancy: a review. Semin Thromb Hemost 1992; 18: 353–372.

    Article  PubMed  CAS  Google Scholar 

  84. Collins RC, Al Mondhiry H, Chernik NL, Posner JB. Neurologic manifestations of intravascular coagulation in patients with cancer. A clinicopathologic analysis of 12 cases. Neurology 1975; 25: 795–806.

    Article  PubMed  CAS  Google Scholar 

  85. Packer RJ, Rorke LB, Lange BJ, Siegel KR, Evans AE. Cerebrovascular accidents in children with cancer. Pediatrics 1985; 76: 194–201.

    PubMed  CAS  Google Scholar 

  86. Reddingius RE, Patte C, Couanet D, Kalifa C, Lemerle J. Dural sinus thrombosis in children with cancer. Med Pediatr Oncol 1997; 29: 296–302.

    Article  PubMed  CAS  Google Scholar 

  87. Liebman HA, Wada JK, Patch MJ, McGehee W. Depression of functional and antigenic plasma antithrombin III (AT-III) due to therapy with L-asparaginase. Cancer 1982; 50: 451–456.

    Article  PubMed  CAS  Google Scholar 

  88. Andrew M, Brooker L, Mitchell L. Acquired antithrombin III deficiency secondary to asparaginase therapy in childhood acute lymphoblastic leukaemia. Blood Coagul Fibrinolysis 1994; 5 (Suppl 1): S24 - S36.

    Article  PubMed  Google Scholar 

  89. Biller J, Challa VR, Toole JF, Howard VJ. Nonbacterial thrombotic endocarditis. A neurologic perspective of clinicopathologic correlations of 99 patients. Arch Neurol 1982; 39: 95–98.

    Article  PubMed  CAS  Google Scholar 

  90. Bedikian A, Valdivieso M, Luna M, Bodey GP. Nonbacterial thrombotic endocarditis in cancer patients: comparison of characteristics of patients with and without concomitant disseminated intravascular coagulation. Med Pediatr Oncol 1978; 4: 149–157.

    Article  PubMed  CAS  Google Scholar 

  91. Rosen P, Armstrong D. Nonbacterial thrombotic endocarditis in patients with malignant neoplastic diseases. Am J Med 1973; 54: 23–29.

    Article  PubMed  CAS  Google Scholar 

  92. Deppisch LM, Fayemi AO. Non-bacterial thrombotic endocarditis: clinicopathologic correlations. Am Heart J 1976; 92: 723–729.

    Article  PubMed  CAS  Google Scholar 

  93. Biller J, Challa VR, Toole JF, Howard VJ. Nonbacterial thrombotic endocarditis. A neurologic perspective of clinicopathologic correlations of 99 patients. Arch Neurol 1982; 39: 95–98.

    Article  PubMed  CAS  Google Scholar 

  94. Rogers LR, Cho ES, Kempin S, Posner JB. Cerebral infarction from non-bacterial thrombotic endocarditis. Clinical and pathological study including the effects of anticoagulation. Am J Med 1987; 83: 746–756.

    Article  PubMed  CAS  Google Scholar 

  95. Atkinson JL, Sundt TM, Jr., Dale AJ, Cascino TL, Nichols DA. Radiation-associated atheromatous disease of the cervical carotid artery: report of seven cases and review of the literature. Neurosurgery 1989; 24: 171–178.

    Article  PubMed  CAS  Google Scholar 

  96. Wingert DJ, Friesen SR, Iliopoulos JI, Pierce GE, Thomas JH, Hermreck AS. Postthyroidectomy hypocalcemia. Incidence and risk factors. Am J Surg 1986; 152: 606–610.

    Article  PubMed  CAS  Google Scholar 

  97. Isaacson SR. Hypocalcemia in surgery for carcinoma of the pharynx and larynx. Otolaryngol Clin North Am 1980; 13: 181–191.

    CAS  Google Scholar 

  98. Fonseca OA, Calverley JR. Neurological manifestations of hypoparathyroidism. Arch Intern Med 1967; 120: 202–206.

    Article  PubMed  CAS  Google Scholar 

  99. Riggs JE. Neurologic manifestations of fluid and electrolyte disturbances. Neurol Clin 1989; 7: 509–523.

    PubMed  CAS  Google Scholar 

  100. Markman M. Common complications and emergencies associated with cancer and its therapy. Cleve Clin J Med 1994; 61: 105–114.

    PubMed  CAS  Google Scholar 

  101. Sorensen JB, Andersen MK, Hansen HH. Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease. J Intern Med 1995; 238: 97–110.

    Article  PubMed  CAS  Google Scholar 

  102. De Troyer A, Demanet JC. Clinical, biological and pathogenic features of the syndrome of inappropriate secretion of antidiuretic hormone. A review of 26 cases with marked hyponatraemia. Q J Med 1976; 45: 521–531.

    PubMed  Google Scholar 

  103. Lokich JJ. Plasma CEA levels in small cell lung cancer. Correlation with stage, distribution of metastases, and survival. Cancer 1982; 50: 2154–2156.

    Article  PubMed  CAS  Google Scholar 

  104. List AF, Hainsworth JD, Davis BW, Hande KR, Greco FA, Johnson DH. The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancer. J Clin Oncol 1986; 4: 1191–1198.

    PubMed  CAS  Google Scholar 

  105. Eliakim R, Vertman E, Shinhar E. Syndrome of inappropriate secretion of antidiuretic hormone in Hodgkin’s disease. Am J Med Sci 1986; 291: 126–127.

    Article  PubMed  CAS  Google Scholar 

  106. Kefford RF, Milton GW. Fatal inappropriate ADH secretion in melanoma. Med J Aust 1986; 144: 333–334.

    PubMed  CAS  Google Scholar 

  107. Kosmidis HV, Bouhoutsou DO, Varvoutsi MC, et al. Vincristine overdose: experience with 3 patients. Pediatr Hematol Oncol 1991; 8: 171–178.

    Article  PubMed  CAS  Google Scholar 

  108. Stahel RA, Oelz O. Syndrome of inappropriate ADH secretion secondary to vinblastine. Cancer Chemother Pharmacol 1982; 8: 253–254.

    Article  PubMed  CAS  Google Scholar 

  109. Levin L, Sealy R, Barron J. Syndrome of inappropriate antidiuretic hormone secretion following dis-dichlorodiammineplatinum II in a patient with malignant thymoma. Cancer 1982; 50: 2279–2282.

    Article  PubMed  CAS  Google Scholar 

  110. Tweedy CR, Silverberg DA, Scott L. Levamisole-induced syndrome of inappropriate antidiuretic hormone. N Engl J Med 1992; 326: 1164.

    Article  PubMed  CAS  Google Scholar 

  111. Hansen M, Pedersen AG. Tumor markers in patients with lung cancer. Chest 1986; 89 (Suppl 4): 2195–2245.

    Article  Google Scholar 

  112. Glover DJ, Glick JH. Metabolic oncologic emergencies. CA Cancer J Clin 1987; 37: 302–320.

    Article  PubMed  CAS  Google Scholar 

  113. Hantman D, Rossier B, Zohlman R, Schrier R. Rapid correction of hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. An alternative treatment to hypertonic saline. Ann Intern Med 1973; 78: 870–875.

    PubMed  CAS  Google Scholar 

  114. Katzman R. Effect of electrolyte disturbance on the central nervous system. Annu Rev Med 1966; 17: 197–212.

    Article  PubMed  CAS  Google Scholar 

  115. Vassilopoulou-Sellin R, Newman BM, Taylor SH, Guinee VF. Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer center. Cancer 1993; 71: 1309–1312.

    Article  PubMed  CAS  Google Scholar 

  116. Pruitt AA. Central nervous system infections in cancer patients. Neurol Clin 1991; 9: 867–888.

    PubMed  CAS  Google Scholar 

  117. Haan J, Caekebeke JF, van der Meer FJ, Wintzen AR. Cerebral venous thrombosis as presenting sign of myeloproliferative disorders. J Neurol Neurosurg Psychiatry 1988; 51: 1219–1220.

    Article  PubMed  CAS  Google Scholar 

  118. Beal MF, O’Carroll CP, Kleinman GM, Grossman RI. Aspergillosis of the nervous system. Neurology 1982; 32: 473–479.

    Article  PubMed  CAS  Google Scholar 

  119. Walsh TJ, Hier DB, Caplan LR. Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients. Ann Neurol 1985; 18: 574–582.

    Article  PubMed  CAS  Google Scholar 

  120. Bach MC, Davis KM. Listeria rhombencephalitis mimicking tuberculous meningitis. Rev Infect Dis 1987; 9: 130–133.

    Article  PubMed  CAS  Google Scholar 

  121. Fujita NK, Reynard M, Sapico FL, Guze LB, Edwards JE Jr. Cryptococcal intra-cerebral mass lesions: the role of computed tomography and nonsurgical management. Ann Intern Med 1981; 94: 382–388.

    PubMed  CAS  Google Scholar 

  122. Viscoli C, Garaventa A, Ferrea G, Manno G, Taccone A, Terragna A. Listeria monocytogenes brain abscesses in a girl with acute lymphoblastic leukaemia after late central nervous system relapse. Eur J Cancer 1991; 27: 435–437.

    Article  PubMed  CAS  Google Scholar 

  123. Lukes SA, Posner JB, Nielsen S, Armstrong D. Bacterial infections of the CNS in neutropenic patients. Neurology 1984; 34: 269–275.

    Article  PubMed  CAS  Google Scholar 

  124. Nemunaitis J, Buckner CD, Dorsey KS, Willis D, Meyer W, Appelbaum F. Retrospective analysis of infectious disease in patients who received recombinant human granulocyte-macrophage colony-stimulating factor versus patients not receiving a cytokine who underwent autologous bone marrow transplantation for treatment of lymphoid cancer. Am J Clin Oncol 1998; 21: 341–346.

    Article  PubMed  CAS  Google Scholar 

  125. Yoshida Y, Nakahata T, Shibata A, Takahashi M, Moriyama Y, Kaku K, et al. Effects of long-term treatment with recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome. Leuk Lymphoma 1995; 18: 457–463.

    Article  PubMed  CAS  Google Scholar 

  126. Macdonald DR. Neurologic complications of chemotherapy. Neurol Clin 1991; 9: 955–967.

    PubMed  CAS  Google Scholar 

  127. Chabner BA, Collins JM (eds.). Cancer and Chemotherapy: Principles and Practice. Philadelphia, PA: JB Lippincott, 1990.

    Google Scholar 

  128. Hurwitz RL, Mahoney DH Jr, Armstrong DL, Browder TM. Reversible encephalopathy and seizures as a result of conventional vincristine administration. Med Pediatr Oncol 1988; 16: 216–219.

    Article  PubMed  CAS  Google Scholar 

  129. DeFronzo RA, Thier SO. Pathophysiologic approach to hyponatremia. Arch Intern Med 1980; 140: 897–902.

    Article  PubMed  CAS  Google Scholar 

  130. Goldberg M. Hyponatremia. Med Clin North Am 1981; 65: 251–269.

    PubMed  CAS  Google Scholar 

  131. Jaffe N, Takaue Y, Anzai T, Robertson R. Transient neurologic disturbances induced by high-dose methotrexate treatment. Cancer 1985; 56: 1356–1360.

    Article  PubMed  CAS  Google Scholar 

  132. Packer RJ, Grossman RI, Belasco JB. High dose systemic methotrexate-associated acute neurologic dysfunction. Med Pediatr Oncol 1983; 11: 159–161.

    Article  PubMed  CAS  Google Scholar 

  133. Walker RW, Allen JC, Rosen G, Caparros B. Transient cerebral dysfunction secondary to high-dose methotrexate. J Clin Oncol 1986; 4: 1845–1850.

    PubMed  CAS  Google Scholar 

  134. Martino RL, Benson AB, III, Merritt JA, Brown JJ, Lesser JR. Transient neurologic dysfunction following moderate-dose methotrexate for undifferentiated lymphoma. Cancer 1984; 54: 2003–2005.

    Article  PubMed  CAS  Google Scholar 

  135. Rubinstein LJ, Herman MM, Long TF, Wilbur JR. Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma. Cancer 1975; 35: 291–305.

    Article  PubMed  CAS  Google Scholar 

  136. Spencer MD. Leukoencephalopathy after CNS prophylaxis for acute lymphoblastic leukaemia. Pediatr Rehabil 1998; 2: 33–39.

    PubMed  CAS  Google Scholar 

  137. Szeto HH, Inturrisi CE, Houde R, Saal S, Cheigh J, Reidenberg MM. Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure of cancer. Ann Intern Med 1977; 86: 738–741.

    PubMed  CAS  Google Scholar 

  138. Gregory RE, Grossman S, Sheidler VR. Grand mal seizures associated with high-dose intravenous morphine infusions: incidence and possible etiology. Pain 1992; 51: 255–258.

    Article  PubMed  CAS  Google Scholar 

  139. Wijdicks EF, Sharbrough FW. New-onset seizures in critically ill patients. Neurology 1993; 43: 1042–1044.

    Article  PubMed  CAS  Google Scholar 

  140. Heim ME, Fiene R, Schick E, Wolpert E, Queisser W. Central nervous side effects following ifosfamide monotherapy of advanced renal carcinoma. J Cancer Res Clin Oncol 1981; 100: 113–116.

    Article  PubMed  CAS  Google Scholar 

  141. Pratt CB, Green AA, Horowitz ME, et al. Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/mesna. J Clin Oncol 1986; 4: 1253–1261.

    PubMed  CAS  Google Scholar 

  142. Cattaneo MT, Filipazzi V, Piazza E, Damiani E, Mancarella G. Transient blindness and seizure associated with cisplatin therapy. J Cancer Res Clin Oncol 1988; 114: 528–530.

    Article  PubMed  CAS  Google Scholar 

  143. Hiesiger EM, Green SB, Shapiro WR, et al. Results of a randomized trial comparing intra-arterial cisplatin and intravenous PCNU for the treatment of primary brain tumors in adults: Brain Tumor Cooperative Group trial 842OA. J Neurooncol 1995; 25: 143–154.

    Article  PubMed  CAS  Google Scholar 

  144. Phillips GL, Fay JW, Herzig GP, et al. Intensive l,3-bis(2-chloroethyl)-1nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study. Cancer 1983; 52: 1792–1802.

    Article  PubMed  CAS  Google Scholar 

  145. Madajewicz S, West CR, Park HC, et al. Phase II study-intra-arterial BCNU therapy for metastatic brain tumors. Cancer 1981; 47: 653–657.

    Article  PubMed  CAS  Google Scholar 

  146. Stein DA, Chamberlain MC. Evaluation and management of seizures in the patient with cancer. Oncology 1991; 5: 33–39.

    PubMed  CAS  Google Scholar 

  147. De Reuck J, vander EH. The anatomy of the late radiation encephalopathy. Eur Neurol 1975; 13: 481–494.

    Article  PubMed  Google Scholar 

  148. Werner-Wasik M, Rudoler S, Preston PE, et al. Immediate side effects of stereo-tactic radiotherapy and radiosurgery. Int J Radiat Oncol Biol Phys 1999; 43: 299–304.

    Article  PubMed  CAS  Google Scholar 

  149. Gelblum DY, Lee H, Bilsky M, Pinola C, Longford S, Wallner K. Radiographic findings and morbidity in patients treated with stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 1998; 42: 391–395.

    Article  PubMed  CAS  Google Scholar 

  150. Bortin MM, Horowitz MM, Rimm AA. Increasing utilization of allogeneic bone marrow transplantation. Results of the 1988–1990 survey. Ann Intern Med 1992; 116: 505–512.

    PubMed  CAS  Google Scholar 

  151. Chen RE, Ramsay DA, deVeber LL, Assis LJ, Levin SD. Immunosuppressive measles encephalitis. Pediatr Neurol 1994; 10: 325–327.

    Article  PubMed  CAS  Google Scholar 

  152. Mookerjee BP, Vogelsang G. Human herpes virus-6 encephalitis after bone marrow transplantation: successful treatment with ganciclovir. Bone Marrow Transplant 1997; 20: 905–906.

    Article  PubMed  CAS  Google Scholar 

  153. Antonini G, Ceschin V, Morino S, et al. Early neurologic complications following allogeneic bone marrow transplant for leukemia: a prospective study. Neurology 1998; 50: 1441–1445.

    Article  PubMed  CAS  Google Scholar 

  154. Graus F, Saiz A, Sierra J, Arbaiza D, et al. Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study. Neurology 1996; 46: 1004–1009.

    Article  PubMed  CAS  Google Scholar 

  155. Madan B, Schey SA. Reversible cortical blindness and convulsions with cyclosporin A toxicity in a patient undergoing allogeneic peripheral stem cell transplantation. Bone Marrow Transplant 1997; 20: 793–795.

    Article  PubMed  CAS  Google Scholar 

  156. Gijtenbeek JM, van den Bent MJ, Vecht CJ. Cyclosporine neurotoxicity: a review. J Neurol 1999; 246: 339–346.

    Article  PubMed  CAS  Google Scholar 

  157. Dalmau J, Graus F. Paraneoplastic syndromes. In: Loeffler JS, Black PMcL (eds.), Cancer of the Nervous System. Boston, MA: Blackwell Science, 1996.

    Google Scholar 

  158. Dalmau J. Paraneoplastic syndromes of the nervous system: General pathogeneic mechanisms and diagnostic approaches. In: Vinken PJ, Bruyn GW, editors: Handbook of Clinical Neurology, vol. 25. Amsterdam: Elsevier, 1997: 319–328.

    Google Scholar 

  159. Dalmau J, Furneaux HM, Rosenblum MK, Graus F, Posner JB. Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy. Neurology 1991; 41: 1757–1764.

    Article  PubMed  CAS  Google Scholar 

  160. Graus F, Elkon KB, Cordon-Cardo C, Posner JB. Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor. Am J Med 1986; 80: 45–52.

    Article  PubMed  CAS  Google Scholar 

  161. Dalmau J, Furneaux HM, Gralla RJ, Kris MG, Posner JB. Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer-a quantitative Western blot analysis. Ann Neurol 1990; 27: 544–552.

    Article  PubMed  CAS  Google Scholar 

  162. Furneaux HF, Reich L, Posner JB. Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Neurology 1990; 40: 1085–1091.

    Article  PubMed  CAS  Google Scholar 

  163. Corsellis JA, Goldberg GJ, Norton AR. “Limbic encephalitis” and its association with carcinoma. Brain 1968; 91: 481–496.

    Article  PubMed  CAS  Google Scholar 

  164. Alamowitch S, Graus F, Uchuya M, René R, Bescansa E, Delattre JY. Limbic encephalitis and small cell lung cancer—Clinical and immunological features. Brain 1997; 120: 923–928.

    Article  PubMed  Google Scholar 

  165. Lucchinetti CF, Kimmel DW, Lennon VA. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology 1998; 50: 652–657.

    Article  PubMed  CAS  Google Scholar 

  166. Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine 1992; 71: 59–72.

    Article  PubMed  CAS  Google Scholar 

  167. Gultekin SH, Voltz R, Gerstner E, et al. Characterization of a novel antineuronal antibody (anti-Ta) in the serum of 6 patients with testicular cancer and paraneoplastic limbic encephalopathy (PLE). Neurology 1998; 50: A383.

    Google Scholar 

  168. Voltz R, Gultekin SH, Rosenfeld MR, et al. A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med 1999; 340: 1788–1795.

    Article  PubMed  CAS  Google Scholar 

  169. Forman AD. Neurologic complications of cytokine therapy. Oncology 1994; 8: 105–110.

    PubMed  CAS  Google Scholar 

  170. Adams F, Fernandez F, Mavligit G. Interferon-induced organic mental disorders associated with unsuspected pre-existing neurologic abnormalities. J Neurooncol 1988; 6: 355–359.

    Article  PubMed  CAS  Google Scholar 

  171. Sherman ML, Spriggs DR, Arthur KA, Imamura K, Frei E, III, Kufe DW. Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism. J Clin Oncol 1988; 6: 344–350.

    PubMed  CAS  Google Scholar 

  172. Steis RG, Urba WJ, VanderMolen LA, et al. Intraperitoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity. J Clin Oncol 1990; 8: 1618–1629.

    PubMed  CAS  Google Scholar 

  173. Moseley RP, Benjamin JC, Ashpole RD, et al. Carcinomatous meningitis: antibody-guided therapy with I-131 HMFG1. J Neurol Neurosurg Psychiatry 1991; 54: 260–265.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Myrna R. Rosenfeld MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Josep Dalmau MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Clinical Neurological Sciences, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland

    Norman Delanty MB, FRCPI (Consultant Neurologist) (Consultant Neurologist)

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Rosenfeld, M.R., Dalmau, J. (2002). Seizures in Cancer Patients. In: Delanty, N. (eds) Seizures. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-094-0_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-094-0_13

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-207-0

  • Online ISBN: 978-1-59259-094-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation